Results from First-in-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

被引：0
|
作者：
Greenberg, Barry
Eshraghian, Emily
Battiprolu, Pavan
Ricks, David
Yarabe, Paul
Schwartz, Jonathan
Patel, Kinnari
Shah, Guarav
Trevejo, Jose
机构：
来源：
CIRCULATION | 2021年 / 144卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10727
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR
    Jasmina Cehajic-Kapetanovic
    Kanmin Xue
    Cristina Martinez-Fernandez de la Camara
    Anika Nanda
    Alexandra Davies
    Laura J. Wood
    Anna Paola Salvetti
    M. Dominik Fischer
    James W. Aylward
    Alun R. Barnard
    Jasleen K. Jolly
    Edmond Luo
    Brandon J. Lujan
    Tuyen Ong
    Aniz Girach
    Graeme C. M. Black
    Ninel Z. Gregori
    Janet L. Davis
    Potyra R. Rosa
    Andrew J. Lotery
    Byron L. Lam
    Paulo E. Stanga
    Robert E. MacLaren
    Nature Medicine, 2020, 26 : 354 - 359
  • [22] Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR
    Cehajic-Kapetanovic, Jasmina
    Xue, Kanmin
    Martinez-Fernandez de la Camara, Cristina
    Nanda, Anika
    Davies, Alexandra
    Wood, Laura J.
    Salvetti, Anna Paola
    Fischer, M. Dominik
    Aylward, James W.
    Barnard, Alun R.
    Jolly, Jasleen K.
    Luo, Edmond
    Lujan, Brandon J.
    Ong, Tuyen
    Girach, Aniz
    Black, Graeme C. M.
    Gregori, Ninel Z.
    Davis, Janet L.
    Rosa, Potyra R.
    Lotery, Andrew J.
    Lam, Byron L.
    Stanga, Paulo E.
    MacLaren, Robert E.
    NATURE MEDICINE, 2020, 26 (03) : 354 - +
  • [23] First-In-Human Gene Therapy for Tay-Sachs Disease: Report of Two Infants Treated on an Expanded Access Clinical Trial of rAAVrh8-HexA/HexB (AXO-AAV-GM2)
    Flotte, Terence R.
    Cataltepe, Oguz
    Puri, Ajit
    Batista, Rita
    Moser, Richard
    Mckenna-Yasek, Diane
    Douthwright, Catherine
    Gernoux, Gwladys
    Blackwood, Meghan
    Mueller, Christian
    Bateman, Scot
    Spanakis, Spiro
    Parzych, Julia
    Keeler, Allison M.
    Abayazeed, Aly
    Gibson, Laura
    Finberg, Robert
    Gounis, Matthew
    Brown, Robert H.
    Gray-Edwards, Heather
    Sena-Esteves, Miguel
    MOLECULAR THERAPY, 2020, 28 (04) : 553 - 554
  • [24] Preliminary safety data of a phase 1 first in-human clinical trial support the use of high dose intrathecal AAV9/CLN7 for the treatment of patients with CLN7 disease
    Kayani, Saima
    Chen, Xin
    Messahel, Souad
    Edgar, Veronica
    Iannaccone, Susan
    Gray, Steven
    Minassian, Berge
    Greenberg, Benjamin
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S65 - S65
  • [25] Single-dose AAV9-CLN6 gene transfer stabilizes motor and language function in CLN6-type Batten disease: Interim results from the first clinical gene therapy trial
    de los Reyes, Emily
    Meyer, Kathrin
    Lehwald, Lenora
    Albright, Charles
    Castelli, Jeff
    Jiang, Hai
    Reha, Allen
    Barth, Jay
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S46 - S47
  • [26] First-in-human trial of PCSK9 gene editing therapy for lowering cholesterol: a new frontier in cardiovascular pharmacotherapy? News from AHA
    Lewis, Basil S.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (02) : 87 - 88
  • [27] AAV8 Gene Therapy as a Potential Treatment in Adults with Late-Onset OTC Deficiency: Results from a Phase 1/2 Clinical Trial
    Tan, Wen-Hann
    Geberhiwot, Tarekegn
    Couce, Maria Luz
    Aldamiz-Echevarria, Luis
    Diaz, George A.
    Harding, Cary O.
    Khan, Aneal
    Lee, Connie
    Puga, Ana Cristina
    Crombez, Eric
    MOLECULAR THERAPY, 2020, 28 (04) : 222 - 222
  • [28] Interim results for RGX-381: a first in human phase 1/2 clinical trial of AAV.CB7.hCLN2 gene therapy for CLN2 Batten disease-associated retinopathy
    Henderson, Robert
    Gissen, Paul
    Prise, Katrina
    Vithlani, Ayeesha
    Cornelius, Sarah
    Roche, Dermot
    Thompson, Dorothy A.
    Buss, Nicholas
    Bailey, Alexander
    Paulo, Falabella
    Huang, Wei Chieh
    Burke, Jenna
    Ohnsman, Christina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [29] Low Seroprevalence Of Neutralizing Antibodies To Adeno-associated Virus Serotype 9 (AAV9) In Preparation For Mypeak-1, The First-in-Human Study Of TN-201, An Investigational AAV9-mediated Gene Therapy For Individuals With MYBPC3-associated Hypertrophic Cardiomyopathy (HCM)
    Haroldson, Jeff
    Massera, Daniele
    Wang, Heng
    Wong, Tmothy c.
    Wever-pinzon, Omar
    Lakdawala, Neil k
    Giudicessi, John
    Abraham, Theodore
    Nagueh, Sherif
    Rader, Florian
    Masr, Ahmad
    Turer, Aslan
    Mushonga, Pfumo
    Butala-flores, Elizabeth
    Harrison, Will
    Wang, Whedy
    Robertson, Laura
    Argast, Gretchen
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [30] AXO-AAV-GM2 Gene Therapy for the Treatment of GM2 Gangliosidosis: Preliminary Results from a Phase 1/2 Trial
    Eichler, F.
    Flotte, T.
    Andonian, H.
    Cataltepe, O.
    Artinian, R.
    Nagy, A.
    Thorp, B.
    Jameson, J.
    Sheehan, M.
    Vaughn, T.
    Valencia, D.
    De Boever, E.
    ANNALS OF NEUROLOGY, 2022, 92 : S169 - S170
12345